CompPharma analyzes clinical and transactional pharmacy data, identifies potential problems and works with payers to improve pharmacy programs. If you want help sorting through the complexity of work comp pharmacy, need expert assistance when evaluating RFPs, or want to see if your PBM really complies with your contract, it’s worth a fact-finding conversation to see if we can help.
Call Joe Paduda at 203-314-2632 or email firstname.lastname@example.org
We provide pharmacy management consulting services to:
Joe Paduda will take self-insured employers on "A Trip Behind the PBM Curtain" at CSIA’s 2019 Employer Summit, October 7. Spread pricing, cost drivers, transparency, rebates, and PBM audits will be discussed. The session starts at 1:45 pm. See the link above for further information.
Joe Paduda provided insight into the Injured Worker Pharmacy (IWP) business model for Boston Globe Reporter Felice Freyer’s article: Andover Pharmacy under investigation for opioid dispensing.
How do healthcare providers price services to group health plans, workers’ compensation, Medicare, Medicaid? Joe will compare what different payers pay for facility, provider and pharmacy services when he speaks at NCSI’s annual meeting in Orlando on June 10.
Pharma Blogs from Joe Paduda
Workers’ comp has done an admirable job reducing the volume and potency of opioids dispensed to work comp patients. This from our latest Survey of Prescription Drug Management in Workers’ Comp… The question is – how many work comp patients … Continue reading Where have all the work comp opioid patients gone?
Reportedly Purdue Pharma, the fine folk behind OxyContin, is nearing a settlement with 23 state attorneys general and thousands of other governmental entities. Here are the key takeaways: this does NOT appear to be a universal settlement; other state AGs, … Continue reading The Purdue Opioid “settlement” – key takeaways for workers’ comp
It’s been a decade since work comp payers and PBMs got the big wakeup call, the one that changed the industry. From looking at drugs just as an expense, the industry began to see how devastating these drugs were to … Continue reading Work comp vs. opioids – how we’re doing